4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-040356
CMO and Head of R&D sold 50,139 shares at an average $3.65 ($183,081)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PRASAD SUYASH CMO and Head of R&D | 2022-06-29 | Sale | −12,324 | $3.81 | $46,954 | 581,265 | D |
| PRASAD SUYASH CMO and Head of R&D | 2022-06-30 | Sale | −13,892 | $3.72 | $51,678 | 567,373 | D |
| PRASAD SUYASH CMO and Head of R&D | 2022-07-01 | Sale | −23,923 | $3.53 | $84,448 | 543,450 | D |
| Open-market sales · 50,139 sh · avg $3.65 · $183,081 | |||||||
Loading xslF345X03/doc4.xml…